{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:05:56Z","timestamp":1765487156616,"version":"3.44.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10528-024-10961-9","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:02:02Z","timestamp":1730808122000},"page":"4723-4739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Knockdown of Inhibin Beta A Reversed the Epithelial Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Enhanced the Therapeutic Effect of Radiotherapy in Non-Small Cell Lung Cancer"],"prefix":"10.1007","volume":"63","author":[{"given":"Hongfei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulizha","family":"Wufuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabiremu","family":"Abuduaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuezhi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"issue":"11","key":"10961_CR1","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.3390\/ijms21114002","volume":"21","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Zarrabi A, Hushmandi K, Kalantari M, Mohammadinejad R, Javaheri T, Sethi G (2020) Association of the epithelial-mesenchymal transition (EMT) with cisplatin resistance. Int J Mol Sci 21(11):4002. https:\/\/doi.org\/10.3390\/ijms21114002","journal-title":"Int J Mol Sci"},{"key":"10961_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12943-015-0433-y","volume":"14","author":"M Basu","year":"2015","unstructured":"Basu M, Bhattacharya R, Ray U, Mukhopadhyay S, Chatterjee U, Roy SS (2015) Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-beta and Activin-A. Mol Cancer 14:162. https:\/\/doi.org\/10.1186\/s12943-015-0433-y","journal-title":"Mol Cancer"},{"issue":"1104","key":"10961_CR3","doi-asserted-by":"publisher","first-page":"20190524","DOI":"10.1259\/bjr.20190524","volume":"92","author":"S Brown","year":"2019","unstructured":"Brown S, Banfill K, Aznar MC, Whitehurst P, Faivre Finn C (2019) The evolving role of radiotherapy in non-small cell lung cancer. Brit J Radiol 92(1104):20190524. https:\/\/doi.org\/10.1259\/bjr.20190524","journal-title":"Brit J Radiol"},{"issue":"10","key":"10961_CR4","doi-asserted-by":"publisher","first-page":"18065","DOI":"10.1002\/jcp.28439","volume":"234","author":"ZL Chen","year":"2019","unstructured":"Chen ZL, Qin L, Peng XB, Hu Y, Liu B (2019) INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF-beta signaling pathway. J Cell Physiol 234(10):18065\u201318074. https:\/\/doi.org\/10.1002\/jcp.28439","journal-title":"J Cell Physiol"},{"issue":"7","key":"10961_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/molecules21070965","volume":"21","author":"B Du","year":"2016","unstructured":"Du B, Shim JS (2016) Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer. Mol (Basel, Switzerland) 21(7):965. https:\/\/doi.org\/10.3390\/molecules21070965","journal-title":"Mol (Basel, Switzerland)"},{"key":"10961_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/b978-0-12-571150-0.50010-x","volume":"50","author":"D Gaddy-Kurten","year":"1995","unstructured":"Gaddy-Kurten D, Tsuchida K, Vale W (1995) Activins and the receptor serine kinase superfamily. Recent Prog Horm Res 50:109\u2013129. https:\/\/doi.org\/10.1016\/b978-0-12-571150-0.50010-x","journal-title":"Recent Prog Horm Res"},{"issue":"5","key":"10961_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14737140.2020.1760094","volume":"20","author":"N Giaj-Levra","year":"2020","unstructured":"Giaj-Levra N, Borghetti P, Bruni A, Ciammella P, Cuccia F, Fozza A, Franceschini D, Scotti V, Vagge S, Alongi F (2020) Current radiotherapy techniques in NSCLC: challenges and potential solutions. Expert Rev Anticanc 20(5):387\u2013402. https:\/\/doi.org\/10.1080\/14737140.2020.1760094","journal-title":"Expert Rev Anticanc"},{"issue":"6","key":"10961_CR8","doi-asserted-by":"publisher","first-page":"675891370","DOI":"10.1177\/03000605211014998","volume":"49","author":"J Guo","year":"2021","unstructured":"Guo J, Liu Y (2021) INHBA promotes the proliferation, migration and invasion of colon cancer cells through the upregulation of VCAN. J Int Med Res 49(6):675891370. https:\/\/doi.org\/10.1177\/03000605211014998","journal-title":"J Int Med Res"},{"issue":"2","key":"10961_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/cbf.3573","volume":"39","author":"Z He","year":"2021","unstructured":"He Z, Liang J, Wang B (2021) Inhibin, beta A regulates the transforming growth factor-beta pathway to promote malignant biological behaviour in colorectal cancer. Cell Biochem Funct 39(2):258\u2013266. https:\/\/doi.org\/10.1002\/cbf.3573","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"10961_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.semradonc.2020.11.009","volume":"31","author":"B Hunter","year":"2021","unstructured":"Hunter B, Crockett C, Faivre-Finn C, Hiley C, Salem A (2021) Re-Irradiation of recurrent non-small cell lung cancer. Semin Radiat Oncol 31(2):124\u2013132. https:\/\/doi.org\/10.1016\/j.semradonc.2020.11.009","journal-title":"Semin Radiat Oncol"},{"issue":"8","key":"10961_CR11","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1158\/1078-0432.CCR-19-2027","volume":"26","author":"K Isomoto","year":"2020","unstructured":"Isomoto K, Haratani K, Hayashi H, Shimizu S, Tomida S, Niwa T, Yokoyama T, Fukuda Y, Chiba Y, Kato R, Tanizaki J, Tanaka K, Takeda M, Ogura T, Ishida T, Ito A, Nakagawa K (2020) Impact of EGFR-TKI treatment on the tumor immune microenvironment in EGFR mutation-positive non-small cell lung cancer. Clin Cancer Res 26(8):2037\u20132046. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2027","journal-title":"Clin Cancer Res"},{"issue":"148","key":"10961_CR12","first-page":"167","volume":"27","author":"S Jonna","year":"2019","unstructured":"Jonna S, Subramaniam DS (2019) Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med 27(148):167","journal-title":"Discov Med"},{"issue":"3","key":"10961_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10961_CR14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/jso.23836","volume":"111","author":"HY Lee","year":"2015","unstructured":"Lee HY, Li CC, Huang CN, Li WM, Yeh HC, Ke HL, Yang KF, Liang PI, Li CF, Wu WJ (2015) INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract. J Surg Oncol 111(4):414\u2013422. https:\/\/doi.org\/10.1002\/jso.23836","journal-title":"J Surg Oncol"},{"key":"10961_CR15","doi-asserted-by":"publisher","first-page":"7275213","DOI":"10.1155\/2019\/7275289","volume":"2019","author":"X Li","year":"2019","unstructured":"Li X, Yang Z, Xu S, Wang Z, Jin P, Yang X, Zhang Z, Wang Y, Wei X, Fang T, Gao Q, Angeletti S (2019) Targeting INHBA in ovarian cancer cells suppresses cancer xenograft growth by attenuating stromal fibroblast activation. Dis Markers 2019:7275213\u20137275289. https:\/\/doi.org\/10.1155\/2019\/7275289","journal-title":"Dis Markers"},{"issue":"1","key":"10961_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13046-019-1093-3","volume":"38","author":"L Liang","year":"2019","unstructured":"Liang L, Hui K, Hu C, Wen Y, Yang S, Zhu P, Wang L, Xia Y, Qiao Y, Sun W, Fei J, Chen T, Zhao F, Yang B, Jiang X (2019) Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2\/STAT3\/VEGFA signaling in non-small cell lung cancer cells. J Exp Clin Canc Res 38(1):71. https:\/\/doi.org\/10.1186\/s13046-019-1093-3","journal-title":"J Exp Clin Canc Res"},{"issue":"4","key":"10961_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00411-020-00867-6","volume":"59","author":"B Liu","year":"2020","unstructured":"Liu B, Chen W, Li H, Li F, Jin X, Li Q (2020) Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1\/CHK2 inhibitor AZD7762. Honokiol and Tunicamycin Radiat Environ Bioph 59(4):723\u2013732. https:\/\/doi.org\/10.1007\/s00411-020-00867-6","journal-title":"Honokiol and Tunicamycin Radiat Environ Bioph"},{"key":"10961_CR18","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2147\/CMAR.S160186","volume":"10","author":"S Lyu","year":"2018","unstructured":"Lyu S, Jiang C, Xu R, Huang Y, Yan S (2018) INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma. Cancer Manag Res 10:1585\u20131596. https:\/\/doi.org\/10.2147\/CMAR.S160186","journal-title":"Cancer Manag Res"},{"issue":"9","key":"10961_CR19","doi-asserted-by":"publisher","first-page":"e239439","DOI":"10.1371\/journal.pone.0239439","volume":"15","author":"Y Miyamoto","year":"2020","unstructured":"Miyamoto Y, Schirripa M, Suenaga M, Cao S, Zhang W, Okazaki S, Berger MD, Matsusaka S, Yang D, Ning Y, Baba H, Loupakis F, Lonardi S, Pietrantonio F, Borelli B, Cremolini C, Yamaguchi T, Lenz HJ (2020) A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer. PLoS ONE 15(9):e239439. https:\/\/doi.org\/10.1371\/journal.pone.0239439","journal-title":"PLoS ONE"},{"issue":"2","key":"10961_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccm.2020.02.008","volume":"41","author":"NJ Myall","year":"2020","unstructured":"Myall NJ, Das M (2020) Advances in the treatment of stage III non-small cell lung cancer. Clin Chest Med 41(2):211\u2013222. https:\/\/doi.org\/10.1016\/j.ccm.2020.02.008","journal-title":"Clin Chest Med"},{"key":"10961_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz4589","author":"MB Nilsson","year":"2020","unstructured":"Nilsson MB, Sun H, Robichaux J, Pfeifer M, McDermott U, Travers J, Diao L, Xi Y, Tong P, Shen L, Hofstad M, Kawakami M, Le X, Liu X, Fan Y, Poteete A, Hu L, Negrao MV, Tran H, Dmitrovsky E, Peng D, Gibbons DL, Wang J, Heymach JV (2020) A YAP\/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaz4589","journal-title":"Sci Transl Med"},{"issue":"2","key":"10961_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1200\/JCO.19.01154","volume":"38","author":"V Noronha","year":"2020","unstructured":"Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, Yadav A, Trivedi V, Behel V, Dutt A, Banavali SD, Prabhash K (2020) Gefitinib versus gefitinib plus pemetrexed and carboplatin chemotherapy in EGFR-mutated lung cancer. J Clin Oncol 38(2):124\u2013136. https:\/\/doi.org\/10.1200\/JCO.19.01154","journal-title":"J Clin Oncol"},{"issue":"2","key":"10961_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ccm.2020.02.010","volume":"41","author":"SA Patel","year":"2020","unstructured":"Patel SA, Weiss J (2020) Advances in the treatment of non-small cell lung cancer: immunotherapy. Clin Chest Med 41(2):237\u2013247. https:\/\/doi.org\/10.1016\/j.ccm.2020.02.010","journal-title":"Clin Chest Med"},{"issue":"37","key":"10961_CR24","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.1038\/s41388-019-0887-2","volume":"38","author":"S Raoof","year":"2019","unstructured":"Raoof S, Mulford IJ, Frisco-Cabanos H, Nangia V, Timonina D, Labrot E, Hafeez N, Bilton SJ, Drier Y, Ji F, Greenberg M, Williams A, Kattermann K, Damon L, Sovath S, Rakiec DP, Korn JM, Ruddy DA, Benes CH, Hammerman PS, Piotrowska Z, Sequist LV, Niederst MJ, Barretina J, Engelman JA, Hata AN (2019) Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer. Oncogene 38(37):6399\u20136413. https:\/\/doi.org\/10.1038\/s41388-019-0887-2","journal-title":"Oncogene"},{"issue":"4","key":"10961_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/JTO.0b013e31819c791a","volume":"4","author":"CW Seder","year":"2009","unstructured":"Seder CW, Hartojo W, Lin L, Silvers AL, Wang Z, Thomas DG, Giordano TJ, Chen G, Chang AC, Orringer MB, Beer DG (2009) INHBA overexpression promotes cell proliferation and may be epigenetically regulated in esophageal adenocarcinoma. J Thorac Oncol 4(4):455\u2013462. https:\/\/doi.org\/10.1097\/JTO.0b013e31819c791a","journal-title":"J Thorac Oncol"},{"issue":"7","key":"10961_CR26","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/JTO.0b013e318216ee52","volume":"6","author":"K Suda","year":"2011","unstructured":"Suda K, Tomizawa K, Fujii M, Murakami H, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T (2011) Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib. J Thorac Oncol 6(7):1152\u20131161. https:\/\/doi.org\/10.1097\/JTO.0b013e318216ee52","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10961_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-020-01477-y","volume":"21","author":"C Sun","year":"2020","unstructured":"Sun C, Gao W, Liu J, Cheng H, Hao J (2020) FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer. Resp Res 21(1):1\u2013210. https:\/\/doi.org\/10.1186\/s12931-020-01477-y","journal-title":"Resp Res"},{"key":"10961_CR28","doi-asserted-by":"publisher","first-page":"598997","DOI":"10.3389\/fbioe.2020.598997","volume":"8","author":"J Tian","year":"2020","unstructured":"Tian J, Wei X, Zhang W, Xu A (2020) Effects of selenium nanoparticles combined with radiotherapy on lung cancer cells. Front Bioeng Biotech 8:598997. https:\/\/doi.org\/10.3389\/fbioe.2020.598997","journal-title":"Front Bioeng Biotech"},{"key":"10961_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13870","author":"SK Vinod","year":"2020","unstructured":"Vinod SK, Hau E (2020) Radiotherapy treatment for lung cancer: current status and future directions. Respirology (Carlton Vic). https:\/\/doi.org\/10.1111\/resp.13870","journal-title":"Respirology (Carlton Vic)"},{"issue":"8","key":"10961_CR30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/kjm2.12387","volume":"37","author":"Z Wang","year":"2021","unstructured":"Wang Z (2021) LncRNA CCAT1 downregulation increases the radiosensitivity of non-small cell lung cancer cells. Kaohsiung J Med Sci 37(8):654\u2013663. https:\/\/doi.org\/10.1002\/kjm2.12387","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"10961_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12943-018-0777-1","volume":"17","author":"SG Wu","year":"2018","unstructured":"Wu SG, Shih JY (2018) Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer. Mol Cancer 17(1):38. https:\/\/doi.org\/10.1186\/s12943-018-0777-1","journal-title":"Mol Cancer"},{"issue":"31","key":"10961_CR32","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1200\/JCO.2018.77.7326","volume":"36","author":"Y Wu","year":"2018","unstructured":"Wu Y, Zhang L, Kim D, Liu X, Lee DH, Yang JC, Ahn M, Vansteenkiste JF, Su W, Felip E, Chia V, Glaser S, Pultar P, Zhao S, Peng B, Akimov M, Tan DSW (2018) Phase Ib\/II study of capmatinib (INC280) plus gefitinib after failure of epidermal growth factor receptor (EGFR) inhibitor therapy in patients with EGFR-mutated, MET factor-dysregulated non-small-cell lung cancer. J Clin Oncol 36(31):3101\u20133109. https:\/\/doi.org\/10.1200\/JCO.2018.77.7326","journal-title":"J Clin Oncol"},{"issue":"1","key":"10961_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12929-020-00676-5","volume":"27","author":"WC Yang","year":"2020","unstructured":"Yang WC, Hsu FM, Yang PC (2020) Precision radiotherapy for non-small cell lung cancer. J Biomed Sci 27(1):82. https:\/\/doi.org\/10.1186\/s12929-020-00676-5","journal-title":"J Biomed Sci"},{"issue":"2","key":"10961_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7888\/juoeh.41.153","volume":"41","author":"K Yoneda","year":"2019","unstructured":"Yoneda K, Imanishi N, Ichiki Y, TANAKA F, (2019) Treatment of non-small cell lung cancer with EGFR-mutations. J UOEH 41(2):153\u2013163. https:\/\/doi.org\/10.7888\/juoeh.41.153","journal-title":"J UOEH"},{"issue":"1","key":"10961_CR35","doi-asserted-by":"publisher","first-page":"9024","DOI":"10.1038\/s41598-020-65920-2","volume":"10","author":"ZY Zhang","year":"2020","unstructured":"Zhang ZY, Gao XH, Ma MY, Zhao CL, Zhang YL, Guo SS (2020) CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p\/MAPK1 axis. Sci Rep-Uk 10(1):9024. https:\/\/doi.org\/10.1038\/s41598-020-65920-2","journal-title":"Sci Rep-Uk"},{"key":"10961_CR36","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12429","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yan S, Li Y, Zhang J, Luo Y, Li P, Yang Y, Li Y, Huang Y, Wang E (2021) Inhibin betaA is an independent prognostic factor that promotes invasion via Hippo signaling in nonsmall cell lung cancer. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12429","journal-title":"Mol Med Rep"},{"key":"10961_CR37","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3389\/fonc.2019.01044","volume":"9","author":"X Zhu","year":"2019","unstructured":"Zhu X, Chen L, Liu L, Niu X (2019) EMT-mediated acquired EGFR-TKI resistance in NSCLC: mechanisms and strategies. Front Oncol 9:1044. https:\/\/doi.org\/10.3389\/fonc.2019.01044","journal-title":"Front Oncol"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10961-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10961-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10961-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:13:16Z","timestamp":1758957196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10961-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10961"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10961-9","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"type":"print","value":"0006-2928"},{"type":"electronic","value":"1573-4927"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"19 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Ili Kazakh Autonomous Prefecture State Friendship Hospital (No. BMR2022-04). This study was performed in line with the principles of the Declaration of Helsinki. All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}}]}}